Janusキナーゼ3阻害剤のパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016414)
◆英語タイトル:Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016414
◆発行日:2019年01月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Janusキナーゼ3阻害剤のパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるJanusキナーゼ3阻害剤のパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・Janusキナーゼ3阻害剤の概要
・Janusキナーゼ3阻害剤のパイプライン概要
・企業別開発中のJanusキナーゼ3阻害剤
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・Janusキナーゼ3阻害剤の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・Janusキナーゼ3阻害剤開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Janus Kinase 3 (JAK3) Inhibitors-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Janus Kinase 3 (JAK3) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Janus Kinase 3 (JAK3) Inhibitors. DelveInsight’s Report also assesses the Janus Kinase 3 (JAK3) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Janus Kinase 3 (JAK3) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Janus Kinase 3 (JAK3) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Janus Kinase 3 (JAK3) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Janus Kinase 3 (JAK3) Inhibitors Overview
• Janus Kinase 3 (JAK3) Inhibitors Disease Associated
• Janus Kinase 3 (JAK3) Inhibitors Pipeline Therapeutics
• Janus Kinase 3 (JAK3) Inhibitors Therapeutics under Development by Companies
• Janus Kinase 3 (JAK3) Inhibitors Filed and Phase III Products
• Comparative Analysis
• Janus Kinase 3 (JAK3) Inhibitors Phase II Products
• Comparative Analysis
• Janus Kinase 3 (JAK3) Inhibitors Phase I and IND Filed Products
• Comparative Analysis
• Janus Kinase 3 (JAK3) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Janus Kinase 3 (JAK3) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Janus Kinase 3 (JAK3) Inhibitors – Discontinued Products
• Janus Kinase 3 (JAK3) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Janus Kinase 3 (JAK3) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Janus Kinase 3 (JAK3) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Janus Kinase 3 (JAK3) Inhibitors, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Monotherapy Products
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Combination Products
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Route of Administration
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Stage and Route of Administration
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Molecule Type
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Stage and Molecule Type
• Janus Kinase 3 (JAK3) Inhibitors Therapeutics – Discontinued Products
• Janus Kinase 3 (JAK3) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Janus Kinase 3 (JAK3) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Janus Kinase 3 (JAK3) Inhibitors, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Monotherapy Products
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Combination Products
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Route of Administration
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Stage and Route of Administration
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Molecule Type
• Janus Kinase 3 (JAK3) Inhibitors Assessment by Stage and Molecule Type


*** レポートのキーワード ***

Janusキナーゼ3阻害剤、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • シクラミン酸ナトリウムの世界市場2015
    The Global Sodium Cyclamate Industry Report 2015 is a professional and in-depth study on the current state of the Sodium Cyclamate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Sodium Cyclamate ma …
  • ヨルダンの再保険市場(~2017)
    "Trends and Opportunities in Jordan Reinsurance Industry to 2017: Market Profile" is the result of extensive research into the reinsurance segment in Jordan. It provides insights into the market trends, market size, growth prospects and market efficiency in the Jordanian reinsurance market.
  • 世界の一般眼科用椅子市場2015
    The Global General Ophthalmology Chair Industry 2015 Market Research Report is a professional and in-depth study on the current state of the General Ophthalmology Chair industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry ch …
  • 化学防護服の世界市場予測
    There are numerous chemicals in an industrial working environment which can affect unprotected skin of a person. These toxic chemical may come in contact with the dermatitis layer present on the skin and can enter into human body, which adversely affect the human body. The use of chemical protective …
  • MPA – Thilawa Deep-Sea Port Expansion – ミャンマーの建設プロジェクト概要
    World Market Intelligence's "MPA – Thilawa Deep-Sea Port Expansion – Myanmar - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the MPA – Thilawa Deep-Sea Port Expansion – Myanmar construction project. World Market Intelli …
  • スマートファーミングにおけるIoTの世界市場2017-2021
    About IoT Market in Smart Farming Internet of things (IoT) refers to automated networks of computers, devices, and sensors that can process their own data. These Internet-connected systems gather data and communicate with external processes via onboard sensors, impacting businesses in every industry …
  • PCIeスロットの世界市場2016
    Notes:Production, means the output of PCIe Slot Revenue, means the sales value of PCIe Slot This report studies PCIe Slot in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with production, price, revenue and market s …
  • 中国の酢酸エチル市場
    China's demand for Ethyl Acetate has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer …
  • 二酸化炭素の世界市場2019
    The Global Carbondioxide (CAS 124-38-9) Industry 2019 Market Research Report is a professional and in-depth study on the current state of the Carbondioxide industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain …
  • Database of Cheese Producers in Norway – Company Names, Financial Performance, Key Executives, and Contact Details
    The industry report Database of Cheese Producers in Norway - Company Names, Financial Performance, Key Executives, and Contact Details offers the most up-to-date perspective on cheese manufacturers in Norway. The report includes details for 16 cheese producers in Norway which makes the report an inv …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016414 )"Janusキナーゼ3阻害剤のパイプライン・インサイト2018" (英文:Janus Kinase 3 (JAK3) Inhibitors -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。